Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy
Authors
Keywords
Gastric cancer, Risk factor, Recurrence, S-1, Adjuvant chemotherapy
Journal
EJSO
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-04-22
DOI
10.1016/j.ejso.2021.04.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial
- (2020) Yoshiaki Iwasaki et al. Gastric Cancer
- Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial
- (2019) Kazuhiro Yoshida et al. JOURNAL OF CLINICAL ONCOLOGY
- Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy
- (2019) Ryo Takahashi et al. Gastric Cancer
- Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset
- (2019) Koki Nakanishi et al. Gastric Cancer
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer
- (2018) Keiji Nishibeppu et al. BMC CANCER
- Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study
- (2018) Simon Pernot et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer
- (2018) Yi-Chu Kao et al. Gastric Cancer
- Is signet-ring cell carcinoma a specific entity among gastric cancers?
- (2015) Thibault Voron et al. Gastric Cancer
- Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge
- (2015) Simon Pernot WORLD JOURNAL OF GASTROENTEROLOGY
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- (2014) Sung Hoon Noh et al. LANCET ONCOLOGY
- Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients
- (2014) Li Chen et al. MEDICAL ONCOLOGY
- A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma
- (2013) Inkeun Park et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Differences in risk factors between patterns of recurrence in patients after curative resection for advanced gastric carcinoma
- (2013) Yoshitsugu Nakanishi et al. World Journal of Surgical Oncology
- Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy
- (2011) Toru Aoyama et al. ANNALS OF SURGICAL ONCOLOGY
- Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
- (2011) Mitsuru Sasako et al. JOURNAL OF CLINICAL ONCOLOGY
- Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical Presentation
- (2009) Guillaume Piessen et al. ANNALS OF SURGERY
- The Clavien-Dindo Classification of Surgical Complications
- (2009) Pierre A. Clavien et al. ANNALS OF SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search